|
|
|
Insider
Information: |
Mansbach Harry H |
Relationship: |
|
City: |
Irvine |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
265,437 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,386,634 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
265,437 |
|
|
Total
Value |
$1,386,634 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
RespireRx Pharmaceuticals Inc |
RSPI |
Chief Medical Officer |
2004-08-30 |
107,000 |
2004-08-30 |
0 |
Premium* |
|
89bio, Inc. |
ETNB |
|
2024-02-17 |
158,437 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2024-02-17 |
4 |
D |
$9.74 |
$10,188 |
D/D |
(1,046) |
158,437 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2024-02-09 |
4 |
D |
$8.45 |
$30,150 |
D/D |
(3,568) |
159,483 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2024-02-05 |
4 |
D |
$9.80 |
$11,662 |
D/D |
(1,190) |
163,051 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
164,241 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2024-01-05 |
4 |
D |
$11.53 |
$111,507 |
D/D |
(9,671) |
115,491 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2024-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
125,162 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-09-09 |
4 |
D |
$16.61 |
$63,467 |
D/D |
(3,821) |
100,162 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-08-17 |
4 |
D |
$15.46 |
$15,676 |
D/D |
(1,014) |
103,983 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-08-01 |
4 |
D |
$15.64 |
$9,024 |
D/D |
(577) |
104,997 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-06-30 |
4 |
D |
$18.95 |
$54,614 |
D/D |
(2,882) |
105,574 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,334 |
108,456 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-02-17 |
4 |
D |
$13.97 |
$29,714 |
D/D |
(2,127) |
94,671 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
96,798 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-02-05 |
4 |
D |
$13.24 |
$18,006 |
D/D |
(1,360) |
66,798 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2023-02-01 |
4 |
D |
$12.05 |
$8,194 |
D/D |
(680) |
68,158 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2022-11-15 |
4 |
D |
$9.79 |
$30,476 |
D/D |
(3,113) |
68,838 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2022-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
71,951 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2022-09-28 |
4 |
D |
$5.76 |
$16,600 |
D/D |
(2,882) |
62,951 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2022-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
65,833 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2022-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
57,500 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2022-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
32,500 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2022-02-05 |
4 |
D |
$5.23 |
$7,128 |
D/D |
(1,363) |
31,137 |
0 |
- |
|
ETNB |
89bio, Inc. |
Chief Medical Officer |
|
2021-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
RSPI |
RespireRx Pharmaceuticals... |
Chief Medical OfficerOfficer |
|
2004-08-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,000 |
|
- |
|
RSPI |
RespireRx Pharmaceuticals... |
Chief Medical Officer |
|
2004-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
107,000 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|